Bullous Pemphigoid that Developed During Nemolizumab Treatment for Atopic Dermatitis: Two Case Reports

Authors

Institutions

Publication Details

Journal
Acta Dermato Venereologica
Published
2024-09-02
DOI
https://doi.org/10.2340/actadv.v104.40634
Citations
4
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
1.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bullous Pemphigoid that Developed During Nemolizumab Treatment for Atopic Dermatitis: Two Case Reports

Akihiko Asahina, Yozo Ishiuji, Michie Katsuta, Ryoichi Kamide et al.
4 citations
Acta Dermato Venereologica
Autoimmune Bullous Skin Diseases
1.70
article

Bullous Pemphigoid that Developed During Nemolizumab Treatment for Atopic Dermatitis: Two Case Reports

Akihiko Asahina, Yozo Ishiuji, Michie Katsuta, Ryoichi Kamide, Yoshimasa Nobeyama
article en
4 citations

Abstract

No abstract available for this paper.
Acta Dermato VenereologicaVol. 104
Jikei University School of Medicine (JP)
Eli Lilly and Company, Pfizer, Sanofi, Jikei University School of Medicine
Openalex Percentile: Top 16%
Autoimmune Bullous Skin Diseases
1.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.